United Therapeutics (UTHR) Q3 Earnings and Revenues Top Estimates
ZacksUnited Therapeutics (UTHR) delivered earnings and revenue surprises of 3.40% and 4.38%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?